Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence

Benzinga
2025.10.23 14:05
portai
I'm PortAI, I can summarize articles.

CARLSBAD, Calif., Oct. 23, 2025 ( GLOBE NEWSWIRE ) -- Exagen Inc. ( NASDAQ:XGN ) , a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology's ( ACR ) annual meeting, ACR Convergence 2025, being held October 24-29, ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.